Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,006,510
+$7,304,629 QoQ
Shares Held
723,262
+901.6% QoQ
Ownership
0.768%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 199 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. REPL ranks #59 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in REPL
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,006,510 | 723,262 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $701,881 | 72,210 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,209,289 | 3,629,902 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,619,524 | 712,543 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $935,775 | 95,977 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $3,438,828 | 283,966 | Shares | Defined | 2025-02-14 | |
| 2022-12-31 | $11,910,880 | 437,900 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $1,205,877 | 69,825 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,282,744 | 187,800 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,514,504 | 854,800 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,219,420 | 340,200 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $6,197,146 | 161,300 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $18,772,131 | 615,278 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $29,951,565 | 785,100 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $22,718,806 | 986,916 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||